BSX
Price
$102.01
Change
-$0.82 (-0.80%)
Updated
Jun 6, 04:12 PM (EDT)
Capitalization
100.1B
47 days until earnings call
PEN
Price
$259.04
Change
+$0.66 (+0.26%)
Updated
Jun 6, 04:59 PM (EDT)
Capitalization
8.64B
60 days until earnings call
Interact to see
Advertisement

BSX vs PEN

Header iconBSX vs PEN Comparison
Open Charts BSX vs PENBanner chart's image
Boston Scientific
Price$102.01
Change-$0.82 (-0.80%)
Volume$3.73K
Capitalization100.1B
Penumbra
Price$259.04
Change+$0.66 (+0.26%)
Volume$1.97K
Capitalization8.64B
BSX vs PEN Comparison Chart
Loading...
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BSX vs. PEN commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSX is a StrongBuy and PEN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (BSX: $102.83 vs. PEN: $258.38)
Brand notoriety: BSX: Notable vs. PEN: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BSX: 97% vs. PEN: 84%
Market capitalization -- BSX: $100.1B vs. PEN: $8.64B
BSX [@Medical Specialties] is valued at $100.1B. PEN’s [@Medical Specialties] market capitalization is $8.64B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BSX’s FA Score shows that 2 FA rating(s) are green whilePEN’s FA Score has 1 green FA rating(s).

  • BSX’s FA Score: 2 green, 3 red.
  • PEN’s FA Score: 1 green, 4 red.
According to our system of comparison, BSX is a better buy in the long-term than PEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BSX’s TA Score shows that 5 TA indicator(s) are bullish while PEN’s TA Score has 5 bullish TA indicator(s).

  • BSX’s TA Score: 5 bullish, 4 bearish.
  • PEN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BSX is a better buy in the short-term than PEN.

Price Growth

BSX (@Medical Specialties) experienced а -1.60% price change this week, while PEN (@Medical Specialties) price change was -2.69% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.07%. For the same industry, the average monthly price growth was +5.30%, and the average quarterly price growth was +1.75%.

Reported Earning Dates

BSX is expected to report earnings on Jul 23, 2025.

PEN is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Medical Specialties (+2.07% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BSX($100B) has a higher market cap than PEN($8.64B). PEN has higher P/E ratio than BSX: PEN (93.70) vs BSX (63.64). BSX YTD gains are higher at: 15.125 vs. PEN (8.801). BSX has higher annual earnings (EBITDA): 3.45B vs. PEN (109M). BSX has more cash in the bank: 865M vs. PEN (289M). PEN has less debt than BSX: PEN (234M) vs BSX (9.49B). BSX has higher revenues than PEN: BSX (14.2B) vs PEN (1.06B).
BSXPENBSX / PEN
Capitalization100B8.64B1,158%
EBITDA3.45B109M3,161%
Gain YTD15.1258.801172%
P/E Ratio63.6493.7068%
Revenue14.2B1.06B1,341%
Total Cash865M289M299%
Total Debt9.49B234M4,056%
FUNDAMENTALS RATINGS
BSX vs PEN: Fundamental Ratings
BSX
PEN
OUTLOOK RATING
1..100
754
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
97
Overvalued
PROFIT vs RISK RATING
1..100
470
SMR RATING
1..100
7085
PRICE GROWTH RATING
1..100
4858
P/E GROWTH RATING
1..100
314
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BSX's Valuation (86) in the Medical Specialties industry is in the same range as PEN (97). This means that BSX’s stock grew similarly to PEN’s over the last 12 months.

BSX's Profit vs Risk Rating (4) in the Medical Specialties industry is significantly better than the same rating for PEN (70). This means that BSX’s stock grew significantly faster than PEN’s over the last 12 months.

BSX's SMR Rating (70) in the Medical Specialties industry is in the same range as PEN (85). This means that BSX’s stock grew similarly to PEN’s over the last 12 months.

BSX's Price Growth Rating (48) in the Medical Specialties industry is in the same range as PEN (58). This means that BSX’s stock grew similarly to PEN’s over the last 12 months.

PEN's P/E Growth Rating (4) in the Medical Specialties industry is in the same range as BSX (31). This means that PEN’s stock grew similarly to BSX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BSXPEN
RSI
ODDS (%)
Bearish Trend 2 days ago
35%
Bullish Trend 2 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
71%
MACD
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
44%
Bearish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
46%
Bearish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 19 days ago
63%
Bullish Trend 8 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
46%
Bearish Trend 16 days ago
70%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HIBS12.150.27
+2.27%
Direxion Daily S&P 500® Hi Bt Br 3X ETF
TEI5.730.02
+0.35%
Templeton Emerging Markets Income Fund
MFEM20.320.04
+0.21%
PIMCO RAFI Dyn Mlt-Fctr Emrg Mkts Eq ETF
IAGG50.78-0.07
-0.14%
iShares Core International Aggt Bd ETF
HQH15.41-0.13
-0.84%
abrdn Healthcare Investors

BSX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BSX has been closely correlated with ISRG. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if BSX jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSX
1D Price
Change %
BSX100%
+0.39%
ISRG - BSX
73%
Closely correlated
+0.02%
SYK - BSX
69%
Closely correlated
+0.14%
MMSI - BSX
62%
Loosely correlated
+1.01%
NTRA - BSX
50%
Loosely correlated
-1.02%
ALC - BSX
49%
Loosely correlated
+1.15%
More